Celebratory Excess Drinking Causes Atrial Arrhythmias
It's New Year's Eve and the ball is about to drop. You and your partner respond to a party that's been going for several hours to care for a person who's dizzy. Making your way through the streamers and horns, you're ushered to a back bedroom where you're introduced to Uncle Bill. Uncle Bill is 52 years old and lying on the bed. He looks up at you and says, "Something's not right, boys." You reach to feel his pulse and ask what he means by his statement. You note the smell of alcohol on his breath as he tells you the evening was going great until he suddenly felt faint and his heart began to race. He sat down and had a glass of water but the symptoms remained. His sister helped him to the bedroom and called 9-1-1. He tells you he never actually passed out nor did he fall or injure himself, and, when asked, he tells you nothing like this has ever happened before. His pulse is about 130 and irregular. His skin is cool and clammy and he's "a little short of breath." Uncle Bill reports a past medical history of hypertension controlled with Prinivil (lisinopril) and high cholesterol treated with Zocor (simvastatin). He also says he's a borderline diabetic but isn't medicated for that condition. When asked about alcohol consumption, he says, "Hey, it's New Year's Eve, of course I've been drinking!" but then says he rarely ever drinks alcohol in excess. Uncle Bill's blood pressure is 100/68 and a dextrose stick reveals a blood glucose level of 200 mg/dL...
Medtronic seems to be on a roll when it comes to innovation. The Dublin-based company has received the greenlight from FDA for an expanded indication of the Kyphon HV-R Bone Cement. Under the new indication, Medtronic can market Kyphon for the fixation of pathological fractures of the sacral vertebral body using sacral vertebroplasty or sacroplasty. Sacral insufficiency fractures (SIFs) are a common cause of debilitating back pain. SIFs mimic the symptoms of lumbar spine pathology. Studies show more than two-thirds of patients diagnosed with SIFs aren't able to associate their pain with a traumatic event. As a result, phys...
CONCLUSIONS: Use of a surfactant-containing polymeric membrane foam wound dressing with glycerin may have facilitated wound closure in 10 of 13 patients who completed the 12-week study.
15-year-old boy from Florida comes in contact with southern flannel moth caterpillar, immediately getting rash, experiencing "the worst pain he ever felt"
This article overviews studies on epidemiology and impact of gastroparesis in the setting of type 1 and type 2 diabetes, with a view to estimating the possible burden of gastrointestinal dysfunction in PPDM. Further, the usefulness of quantifying gastrointestinal dysmotility is discussed. The gastroparesis cardinal symptom index has emerged as a standardised gastrointestinal dysmotility endpoint and its use in individuals after pancreatitis is justified. PMID: 29914234 [PubMed - as supplied by publisher]
CONCLUSIONS: The intention and motivation to alcohol dependence treatment seem to be high at the beginning of the treatment, but recognition of the alcohol problems were low in highly dependent patients. Marital status was connected with an increased active component for readiness to change. The passive component (decreasing the ambivalence) was observed in the unmarried patients. PMID: 29919989 [PubMed - as supplied by publisher]
(Reuters Health) - Even when the heart rhythm disorder known as atrial fibrillation goes away after treatment, patients' risk of stroke may still be higher than average, a large UK study suggests.
CONCLUSIONS: Our results, albeit preliminary, suggest that a curcumin-phospholipid formulation (Meriva®), administered as Norflo® tablets, may be feasible in the improvement of visual acuity and reduction of macular edema in patients with diabetic retinopathy. PMID: 29917217 [PubMed - in process]
Authors: Chen Y, Men K, Li XF, Li J, Liu M, Fan ZQ Abstract OBJECTIVE: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral antidiabetic agents for type 2 diabetes mellitus (T2DM) patients. However, the effects and safety of DPP-4 inhibitors in T2DM patients with renal impairment (RI) remain controversial. Therefore, we conducted this meta-analysis to assess the efficacy and safety of DPP-4 inhibitors in T2DM patients with moderate to severe RI. MATERIALS AND METHODS: The PubMed, Embase, and Web of Science database were searched for published randomized controlled trials (RCTs), which compared DPP-...
CONCLUSIONS: Children with type 1 diabetes mellitus can experience difficulties in cognitive functioning, as a consequence of high HbA1c. Additional research, involving a larger group of patients and a wider age range when the disease was diagnosed, will enable further findings on the occurrence of cognitive impairment in T1DM. PMID: 29917198 [PubMed - in process]